Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Tandem Diabetes Care | TNDM | Nov 25, 2024 | 30.42 | -1.27 |
Tanger | SKT | Nov 25, 2024 | 36.67 | +0.49 |
Tango Therapeutics | TNGX | Nov 25, 2024 | 3.80 | -3.06 |
Tantech | TANH | Nov 25, 2024 | 0.15 | -1.13 |
Taoping | TAOP | Nov 25, 2024 | 0.34 | +0.56 |
Tapestry | TPR | Nov 25, 2024 | 60.85 | +3.28 |
Targa Resources | TRGP | Nov 25, 2024 | 201.06 | -3.01 |
Target | TGT | Nov 25, 2024 | 130.53 | +4.42 |
Target Global Acquisition I A | TGAA | Nov 25, 2024 | 11.35 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Nov 25, 2024 | 11.28 | 0.00 |
Target Hospitality | TH | Nov 25, 2024 | 8.42 | -3.33 |
Tarsus Pharmaceuticals | TARS | Nov 25, 2024 | 48.32 | +0.17 |
Taseko Mines | TGB | Nov 25, 2024 | 2.06 | -0.96 |
TaskUs A | TASK | Nov 25, 2024 | 15.12 | +2.02 |
TAT Technologies | TATT | Nov 25, 2024 | 22.36 | +0.56 |
Taylor Devices | TAYD | Nov 25, 2024 | 46.62 | +0.47 |
Taylor Morrison Home | TMHC | Nov 25, 2024 | 74.80 | +5.23 |
Taysha Gene Therapies | TSHA | Nov 25, 2024 | 2.89 | +17.00 |
TC Bancshares | TCBC | Nov 25, 2024 | 13.10 | 0.00 |
TC Biopharm ADR | TCBP | Nov 25, 2024 | 0.66 | +5.15 |
TC Energy | TRP | Nov 25, 2024 | 49.06 | -1.58 |
TCTM Kids IT Education ADR | TCTM | Nov 25, 2024 | 0.83 | +2.46 |
TCW Strategic | TSI | Nov 25, 2024 | 4.97 | +0.40 |
TD Synnex | SNX | Nov 25, 2024 | 120.97 | +1.81 |
TDH Holdings | PETZ | Nov 25, 2024 | 1.19 | +2.59 |
TE Connectivity | TEL | Nov 25, 2024 | 152.73 | +0.31 |
Team | TISI | Nov 25, 2024 | 16.75 | -4.61 |
TechnipFMC Plc | FTI | Nov 25, 2024 | 30.64 | -0.62 |
Technology & Telecommunication Acquisition A | TETE | Nov 25, 2024 | 12.21 | 0.00 |
Technology Alphadex First Trust | FXL | Nov 25, 2024 | 155.35 | +0.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.